-
4
-
-
0036231063
-
-
and references therein
-
See for example: el Kouni, M. H. Curr. Pharm. Des. 2002, 8, 581; and references therein.
-
(2002)
Curr. Pharm. Des.
, vol.8
, pp. 581
-
-
El Kouni, M.H.1
-
5
-
-
0034084321
-
-
and references therein
-
(a) See for example: Kukhanova, M.; Krayevsky, A.; Prusoff, W.; Cheng, Y. C. Curr. Pharm. Design 2000, 6, 585; and references therein,
-
(2000)
Curr. Pharm. Design
, vol.6
, pp. 585
-
-
Kukhanova, M.1
Krayevsky, A.2
Prusoff, W.3
Cheng, Y.C.4
-
6
-
-
11144357250
-
-
(b) Erion, M. D.; Raja Reddy, K.; Boyer, S. H.; Matelich, M. C.; Gomez-Galeno, J.; Lemus, R. H.; Ugarkar, B. G.; Colby, T. J.; Schanzer, J.; van Poelje, P. D. J. Am. Chem. Soc. 2004, 126, 5154.
-
(2004)
J. Am. Chem. Soc.
, vol.126
, pp. 5154
-
-
Erion, M.D.1
Raja Reddy, K.2
Boyer, S.H.3
Matelich, M.C.4
Gomez-Galeno, J.5
Lemus, R.H.6
Ugarkar, B.G.7
Colby, T.J.8
Schanzer, J.9
Van Poelje, P.D.10
-
8
-
-
0036137190
-
-
For a recent review of ribose-modified nucleosides, see: Ichikawa, E.; Kato, K. Synthesis 2002, 1.
-
(2002)
Synthesis
, pp. 1
-
-
Ichikawa, E.1
Kato, K.2
-
9
-
-
0022630574
-
-
Ravenscroft, P.; Newton, R. F.; Scopes, D. I. C. Tetrahedron Lett. 1986, 27, 747.
-
(1986)
Tetrahedron Lett.
, vol.27
, pp. 747
-
-
Ravenscroft, P.1
Newton, R.F.2
Scopes, D.I.C.3
-
10
-
-
0032765470
-
-
(a) Ogawa, A.; Shuto, S.; Tanaka, M.; Sasaki, T.; Mori, S.; Shigeta, S.; Matsuda, A. Chem. Pharm. Bull. 1999, 47, 1000.
-
(1999)
Chem. Pharm. Bull.
, vol.47
, pp. 1000
-
-
Ogawa, A.1
Shuto, S.2
Tanaka, M.3
Sasaki, T.4
Mori, S.5
Shigeta, S.6
Matsuda, A.7
-
12
-
-
0037144693
-
-
(c) Hong, J. H.; Shim, M. J.; Ro, B. O.; Ko, O. H. J. Org. Chem. 2002, 67, 6837.
-
(2002)
J. Org. Chem.
, vol.67
, pp. 6837
-
-
Hong, J.H.1
Shim, M.J.2
Ro, B.O.3
Ko, O.H.4
-
13
-
-
0034670585
-
-
(d) Crimmins,M. T.; King, B. W.; Zuercher, W. J.; Choy, A. L. J. Org. Chem. 2000, 65, 8499.
-
(2000)
J. Org. Chem.
, vol.65
, pp. 8499
-
-
Crimmins, M.T.1
King, B.W.2
Zuercher, W.J.3
Choy, A.L.4
-
14
-
-
0035861034
-
-
(a) Louie, J.; Bielawski, C. W.; Grubbs, R. H. J. Am. Chem. Soc. 2001, 123, 11312.
-
(2001)
J. Am. Chem. Soc.
, vol.123
, pp. 11312
-
-
Louie, J.1
Bielawski, C.W.2
Grubbs, R.H.3
-
16
-
-
0026697869
-
-
Agrofoglio, L.; Condom, R.; Guedj, R. Tetrahedron Lett. 1992, 33, 5503.
-
(1992)
Tetrahedron Lett.
, vol.33
, pp. 5503
-
-
Agrofoglio, L.1
Condom, R.2
Guedj, R.3
-
18
-
-
0028136760
-
-
Asami, M.; Takahashi, J.; Inoue, S. Tetrahedron: Asymmetry 1994, 5, 1649.
-
(1994)
Tetrahedron: Asymmetry
, vol.5
, pp. 1649
-
-
Asami, M.1
Takahashi, J.2
Inoue, S.3
-
19
-
-
0033545678
-
-
Shi, J.; McAtee, J.; Wirtz, S.; Tharnish, P.; Juodawlkis, A.; Liotta, D. C.; Schinazi, R. F. J. Med. Chem. 1999, 42, 859.
-
(1999)
J. Med. Chem.
, vol.42
, pp. 859
-
-
Shi, J.1
McAtee, J.2
Wirtz, S.3
Tharnish, P.4
Juodawlkis, A.5
Liotta, D.C.6
Schinazi, R.F.7
-
20
-
-
15944403033
-
-
note
-
Assumed to be the diastereoisomer shown by direct analogy to literature reports for such π-allyl Pd-mediated base attachments.7.
-
-
-
-
21
-
-
15944400869
-
-
note
-
Assignment of facial selectivity for the initial osmylation, and cis- and trans-diols was made by proton NMR methods (Figure 2), by firstly rigorously assigning each proton using COSY, followed by NOE experiments (vide infra). (Diagram presented) Figure 2 NOE assignments for the cis-diol 27 and the trans-diol 30.
-
-
-
-
22
-
-
15944379071
-
-
note
-
+. Chemical purity by HPLC, Synergy
-
-
-
-
23
-
-
15944397128
-
-
note
-
4, pH7, 96.97% (261 nm).
-
-
-
-
24
-
-
15944390430
-
-
note
-
3): δ = 0.06 (s, 6 H), 0.85 (s, 9 H), 1.49 (dt, 1 H), 2.02 (s, 3 H), 2.39 (dt, 1 H), 2.80 (m, 1 H), 3.52 (d, 2 H), 5.62 (m, 1 H), 5.84 (m, 1 H), 6.02 (m, 1 H).
-
-
-
-
25
-
-
15944374534
-
-
note
-
4, pH 2.5, 97.82% (270 nm).
-
-
-
|